Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
1.
J Neurosurg Spine ; 25(5): 646-653, 2016 Nov.
Article de Anglais | MEDLINE | ID: mdl-27341054

RÉSUMÉ

OBJECTIVE This study is a multi-institutional pooled analysis specific to imaging-based local control of spinal metastases in patients previously treated with conventional external beam radiation therapy (cEBRT) and then treated with re-irradiation stereotactic body radiotherapy (SBRT) to the spine as salvage therapy, the largest such study to date. METHODS The authors reviewed cases involving 215 patients with 247 spinal target volumes treated at 7 institutions. Overall survival was calculated on a patient basis, while local control was calculated based on the spinal target volume treated, both using the Kaplan-Meier method. Local control was defined as imaging-based progression within the SBRT target volume. Equivalent dose in 2-Gy fractions (EQD2) was calculated for the cEBRT and SBRT course using an α/ß of 10 for tumor and 2 for both spinal cord and cauda equina. RESULTS The median total dose/number of fractions of the initial cEBRT was 30 Gy/10. The median SBRT total dose and number of fractions were 18 Gy and 1, respectively. Sixty percent of spinal target volumes were treated with single-fraction SBRT (median, 16.6 Gy and EQD2/10 = 36.8 Gy), and 40% with multiple-fraction SBRT (median 24 Gy in 3 fractions, EQD2/10 = 36 Gy). The median time interval from cEBRT to re-irradiation SBRT was 13.5 months, and the median duration of patient follow-up was 8.1 months. Kaplan-Meier estimates of 6- and 12-month overall survival rates were 64% and 48%, respectively; 13% of patients suffered a local failure, and the 6- and 12-month local control rates were 93% and 83%, respectively. Multivariate analysis identified Karnofsky Performance Status (KPS) < 70 as a significant prognostic factor for worse overall survival, and single-fraction SBRT as a significant predictive factor for better local control. There were no cases of radiation myelopathy, and the vertebral compression fracture rate was 4.5%. CONCLUSIONS Re-irradiation spine SBRT is effective in yielding imaging-based local control with a clinically acceptable safety profile. A randomized trial would be required to determine the optimal fractionation.


Sujet(s)
Radiochirurgie/méthodes , Réirradiation/méthodes , Thérapie de rattrapage/méthodes , Tumeurs du rachis/secondaire , Tumeurs du rachis/chirurgie , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Études de cohortes , Femelle , Études de suivi , Humains , Estimation de Kaplan-Meier , Mâle , Adulte d'âge moyen , Radiochirurgie/effets indésirables , Dosimétrie en radiothérapie , Réirradiation/effets indésirables , Thérapie de rattrapage/effets indésirables , Tumeurs du rachis/mortalité , Rachis/chirurgie , Facteurs temps , Résultat thérapeutique , Jeune adulte
2.
J Neurosurg Spine ; 24(4): 652-9, 2016 Apr.
Article de Anglais | MEDLINE | ID: mdl-26682603

RÉSUMÉ

OBJECT: The authors performed a pattern-of-failure analysis, with a focus on epidural disease progression, in patients treated with postoperative spine stereotactic body radiotherapy (SBRT). METHODS: Of the 70 patients with 75 spinal metastases (cases) treated with postoperative spine SBRT, there were 26 cases of local disease recurrence and 25 cases with a component of epidural disease progression. Twenty-four of the 25 cases had preoperative epidural disease with subsequent epidural disease progression, and this cohort was the focus of this epidural-specific pattern-of-failure investigation. Preoperative, postoperative, and follow-up MRI scans were reviewed, and epidural disease was characterized based on location according to a system in which the vertebral anatomy is divided into 6 sectors, with the anterior compartment comprising Sectors 1, 2, and 6, and the posterior compartment comprising Sectors 3, 4, and 5. RESULTS: Patterns of epidural progression are reported specifically for the 24 cases with preoperative epidural disease and subsequent epidural progression. Epidural disease progression within the posterior compartment was observed to be significantly lower in those with preoperative epidural disease confined to the anterior compartment than in those with preoperative epidural disease involving both anterior and posterior compartments (56% vs. 93%, respectively; p = 0.047). In a high proportion of patients with epidural disease progression, treatment failure was found in the anterior compartment, including both those with preoperative epidural disease confined to the anterior compartment and those with preoperative epidural disease involving both anterior and posterior compartments (100% vs. 73%, respectively). When epidural disease was confined to the anterior compartment on the preoperative and postoperative MRIs, no epidural disease progression was observed in Sector 4, which is the most posterior sector. Postoperative epidural disease characteristics alone were not predictive of the pattern of epidural treatment failure. CONCLUSIONS: Reviewing the extent of epidural disease on preoperative MRI is imperative when planning postoperative SBRT. When epidural disease is confined to the anterior epidural sectors pre- and postoperatively, covering the entire epidural space circumferentially with a prophylactic "donut" distribution may not be needed.


Sujet(s)
Néphrocarcinome/chirurgie , Fractionnement de la dose d'irradiation , Tumeurs du rein/chirurgie , Récidive tumorale locale/chirurgie , Tumeurs du rachis/chirurgie , Rachis/chirurgie , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Néphrocarcinome/anatomopathologie , Évolution de la maladie , Femelle , Humains , Tumeurs du rein/diagnostic , Imagerie par résonance magnétique/méthodes , Mâle , Adulte d'âge moyen , Radiochirurgie/méthodes , Jeune adulte
3.
Oral Oncol ; 51(6): e57-9, 2015 Jun.
Article de Anglais | MEDLINE | ID: mdl-25865552

RÉSUMÉ

Head-and-neck small cell carcinoma (HN-SmCC) is a rare entity and there is limited data to support management decisions. The role of prophylactic cranial irradiation (PCI) remains controversial. A retrospective review of 21 consecutive HN-SmCCs was performed. No case received PCI. The 2-year overall survival, local, regional and distant control rates were 65%, 94%, 88%, and 76% respectively. Despite no patient receiving PCI, brain metastases were uncommon (n=2) and routine use of PCI is not justified in this population.


Sujet(s)
Carcinome à petites cellules/mortalité , Carcinome à petites cellules/thérapie , Irradiation crânienne/statistiques et données numériques , Tumeurs de la tête et du cou/mortalité , Tumeurs de la tête et du cou/thérapie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Tumeurs du cerveau/secondaire , Carcinome à petites cellules/secondaire , Femelle , Tumeurs de la tête et du cou/anatomopathologie , Humains , Mâle , Adulte d'âge moyen , Pronostic , Études rétrospectives , Taux de survie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE